Loading...
Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy
The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes is steadily increasing. SGLT2 inhibitors are associated with weight loss, lowering of blood pressure, and low hypoglycemia risk along with beneficial cardiovascular and renoprotective effects. In view o...
Na minha lista:
| Udgivet i: | Case Rep Endocrinol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6526544/ https://ncbi.nlm.nih.gov/pubmed/31198610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3901741 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|